Here's a summary of 9 recent articles on cognitive behavioral and mindfulness-based treatments, selected for their their clinical relevance, applicability, and quality.
To support patients with breast cancer, psychiatrists should be aware of possible medication interactions, psychiatric or neurologic adverse effects of treatment, and signs of disease progression-—issues that are the focus here.
When treating psychosis, dementia, addiction, and other psychiatric illnesses in older patients, clinicians must be prepared for a multitude of scenarios.
While most clinicians know about Huntington disease, they may not be aware of its devastating effect in cognition and behavior during onset in childhood and adolescence.
What do we know about the relative efficacy of current medication and therapy for OCD? This question answered and highlights of recent studies, future directions, and causes are summarized in this video.
An expert summarizes the effectiveness of the treatments for obsessive-compulsive disorder, including pharmacotherapy and a very specific type of cognitive behavioral therapy.
Mindfulness training is a viable treatment tool that rivals psychopharmaceutical agents for the treatment of addiction, anxiety, depression, and other psychiatric disorders.
Anxiety is a fundamental aspect of the human experience, but if it impacts social, psychological, or physiological functioning, it can lead to symptoms that cause distress and impairment. Here: the latest on anxiety disorders by experts in the field.
It has been estimated that depression alone results in a loss of $31 billion per year for employers. This slideshow reports findings from a survey on work psychiatry.
Keys to the management of panic disorder include appropriate use of psychotropic medication and psychotherapy predicated on an understanding of the disorder's biopsychosocial underpinnings. Here, Stephen V. Sobel, MD, focuses on treatment options.
![Subscribe to Anxiety on [sitename]](http://www.psychiatrictimes.com/misc/feed.png){kind=small}
